Formulation and Drug Delivery

Recipharm Acquires Respiratory Drug Site

June 14, 2018

Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.

Cambrex Adds R&D Lab for Generic APIs

June 13, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Cambrex expands its generic API research and development capabilities at its Milan, Italy site.

MilliporeSigma Opens Technical Support Center

June 08, 2018

MilliporeSigma targets emerging biotechs with US development center and global grants.

Report Shows Bioscience Industry Has $2-Trillion Economic Impact

June 07, 2018

A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.

GE Healthcare Equips China Cell Therapy Manufacturing Plant with FlexFactory

June 07, 2018

The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.

Vetter Launches Use-Centered Approach to Improve Injections

June 07, 2018

Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.

FDA Approves First Biosimilar to Amgen’s Neulasta

June 05, 2018

The agency has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first US-approved biosimilar to Amgen’s Neulasta (pegfilgrastim) to reduce infection risk during cancer treatment.

EMA Recommends Four Biosimilars for Approval

June 04, 2018

The agency has recommended approval of three biosimilar adalimumab products from Novartis, referencing AbbVie’s Humira, and a biosimilar trastuzumab from Pfizer, referencing Roche’s Herceptin.

EMA Recommends Approval of Migraine Biologic

June 04, 2018

EMA has recommended marketing authorization for Aimovig (erenumab), a new treatment for migraine.

Emerging Technologies Advance Oral Drug Delivery

June 02, 2018

New approaches enable more patient-centric drug design that offers improved outcomes.